Produkty 22350-43-2

CAS 22350-43-2 występuje w naszej ofercie pod nazwami: Cholecalciferol EP Impurity D (iso-Tachysterol 3), Cholecalciferol Impurity 4（Cholecalciferol EP Impurity D）, Isotachysterol3, 90%, Isotachysterol 3, Isotachysterol 3. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, GLPBio, Biosynth. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 5mg, 1 mg.

Cholecalciferol EP Impurity D (iso-Tachysterol 3)
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
Cholecalciferol Impurity 4（Cholecalciferol EP Impurity D）
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
Isotachysterol3, 90%
TRC
  • opakowanie: 25mg, 50mg, 5mg
  • Warianty: 3
Zobacz produkt
Isotachysterol 3
GLPBio
  • opakowanie: 10mg, 25mg, 5mg, 50mg
  • Warianty: 4
od 1065,09
Zobacz produkt
Isotachysterol 3
Biosynth, Fluorochem
  • opakowanie: 5mg, 10mg, 25mg
  • Warianty: 4
od 5496,00
Zobacz produkt
Isotachysterol 3, 87.02%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 649,42
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol (CAS 22350-43-2) to związek chemiczny o wzorze sumarycznym C27H44O i masie molowej 384.6 g/mol. Nazwa systematyczna IUPAC: (1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol. InChIKey: ZPZNWLRQHDLNNV-QVEMQNNUSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H44O
Masa molowa384.6 g/mol
Nazwa IUPAC(1S)-3-[(E)-2-[(1R,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,5,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
InChIKeyZPZNWLRQHDLNNV-QVEMQNNUSA-N
SMILESCC1=C(C[C@H](CC1)O)/C=C/C2=C3CC[C@@H]([C@]3(CCC2)C)[C@H](C)CCCC(C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Isotachysterol 3, isotachysterol3, Cholecalciferol impurity D, Toxisterol3 D3, CHOLECALCIFEROL IMPURITY D (EP), (6E)-(3S)-9,10-seco-5(10),6,8(14)-cholestatrien-3-ol, 9,10-Secocholesta-5(10),6,8(14)-trien-3beta-ol, (E)-, 9,10-Secocholesta-5(10),6,8(14)-trien-3-ol, (3beta,6E)-, Cholecalciferol EP Impurity D, Isotachysterol3, 90%
Izomery (ten sam wzór sumaryczny)
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-(trideuteriomethyl)hept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6,7,7,7-tetradeuterio-6-(trideuteriomethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(3S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol C27H44O
(1S)-3-[(Z)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O
(1S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohex-3-en-1-ol C27H44O
(3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H44O